COLL - Collegium Pharmaceutical Inc Company Long-Term Liabilities

Brandmark of Collegium Pharma (COLL)

Collegium Pharmaceutical (COLL) focuses on the therapy of severe pain syndromes, capturing a massive US opioid segment by developing safe drug formulations. Despite patent protection, pricing power is constrained by insurance company requirements. The price action of specific long-term debt is 1.09, while the business generates revenue from supplying prescription medications to pharmacy chains and specialized medical centers.

collegiumpharma.com (COLL) Company Long-Term Liabilities: for the period 07/04/2022 - 10/29/2026

Collegium Pharmaceutical Inc (COLL) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
Price Performance Chart collegiumpharma.com|COLL - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Collegium Pharmaceutical|COLL - Total Company Value
- shareholders' equity book value data:
Net Asset Value per Share Collegium Pharmaceutical|COLL - Company Net Assets|Market Value to Book Value collegiumpharma.com|COLL - Company Total Assets
- debt level and financial liquidity data:
Aggregate Debt to Equity Collegium Pharmaceutical|COLL - Long-Term Debt to Capital|Short-Term Debt to Capital Collegium Corp|COLL - Company Debts|Debt to Net Assets Ratio Collegium Pharmaceutical|COLL - Company Long-Term Debt|Company Current Liabilities Collegium Pharmaceutical
Analysis of all company metrics:collegiumpharma.com
Finished products of Collegium Pharmaceutical Inc

Fundamental stock selection requires an analysis of the liability structure to assess business resilience to borrowing costs. This indicator captures the volume of credit obligations with a maturity of over one year, which on the GURU.Markets platform, via the issuer's long-term liabilities, allows for an assessment of the ability of Collegium Pharmaceutical (COLL) to finance its defensive analgesic ecosystem without a critical debt load.

Competitors of Collegium Pharmaceutical (COLL)

Company Long-Term Loans and Borrowings INDV|Cronos Group - Company Long-Term Debts|Canopy Growth Corp (CGC) - Company Long-Term Liabilities|High Tide Corp (HITI) - Company Long-Term Debt|Long-Term Debt Aurora Cannabis Inc. (ACB)|Company Long-Term Liabilities ACHV|SKYE: Company Long-Term Loans and Borrowings|Company Long-Term Debts ANEB|INCR: Long-Term Liabilities|Company Long-Term Debts NTRB (Nutriband)|Company Long-Term Debts Nasus Pharma Ltd. NSRX|IGC - Company Long-Term Debt|Company Long-Term Loans and Borrowings MIRA (MIRA Pharmaceuticals)|Flora Growth (FLGC) - Company Long-Term Debt|Company Long-Term Liabilities IM Cannabis|ADIL (Adial Pharmaceuticals Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Artelo (ARTL)|Company Long-Term Debt Ensysce Biosciences (ENSC)|TTNP - Long-Term Debt|Company Long-Term Debt Greenlane GNLN|InMed Pharmaceuticals Inc - Company Long-Term Debt|AKAN - Company Long-Term Debt|ENVB: Company Long-Term Debt|BGXX: Company Long-Term Debts|Long-Term Debt hempaccoinc.com (HPCO)